pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·1d ago·1 min read
save

Grand Central Bakery recalls potato sourdough loaves over possible metal fragments

Aug 13, 2026·read at fda recalls ↗RegulatoryNegative

Grand Central Bakery of Seattle announced a recall of its potato sourdough bread after discovering that some loaves may contain pieces of metal.

The recall includes 20‑oz, 12‑oz and other sized loaves sold on August 10, 2026 at grocery stores, select restaurants, wholesalers and four GCB café locations in the Seattle and Tacoma metro areas.

Consumers are instructed not to eat the product and to return it to the point of purchase or discard it. The FDA posted the recall notice on August 14, 2026.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “Grand Central Bakery Recalls Potato Sourdough Bread Due to Possible Foreign Object”

read at fda recalls ↗
302 words · retrieved 13h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall7

related stories

  • Jul 24STAT+: Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and moreSTAT
  • Jul 21Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeFierce Biotech
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21A renewed push from the right against abortion pillsSTAT
  • Jul 20FDA still focused on lettuce supplier as source of parasite, despite faulty test resultSTAT